NOSTALAB is reimagining health and wellness from the front seat of Einstein’s car traveling at the speed of light. We are envisioning the future—empowered by technology, brilliance and perseverance—of digital health and the bold future of medicine. We move very fast, yet we rarely blink.
We know the rest mass of an electron. We also know role of calcium in the contractile process of the ventricular myocardium. NOSTALAB uniquely and intimately understands the science, technology and humanity that together weave the magic of digital health. And beyond simple understanding, we’ve actually defined some of these very trends and issues. You see, we are far from passive observers—we are digital health.
Thinking is what we do best. We apply our thinking to solve creative and strategic problems that seems either insurmountable or unthinkable. At times, we’ve even discovered new problems and challenges and proactively sought out solutions as preemptive strikes against second rate thinking.
We are digital. We are health. We are also defiant, bold and closely connected to imaginative thinkers and risk-takers who define digital health. Our philosophy is grounded in brilliance yet our methodology has often pushed us over the “practical ledge” and forced us to build wings on the way down. We like to fly.
There is no more pressing issue in today’s world than health. And for as long as most can remember, the solutions are been largely the same. The stethoscope, an iconic symbol of medicine and the physical exam is a perfect example. It has changed little from the times of inventor Rene Leannec in 1817. Yet it still hangs over the shoulders of clinicians like a prayer shawl or a badge of clinical validation.
This is changing, changing rapidly. The advances in technology are disturbing, challenging and empowering a new “social collective” that will change medicine at its very core. From data to people, digital health is poised to establish a new medical society driven less by the oppressive hegemony of today’s system but by the birth of the citizen scientist and the empowered patient.
Why NOSTALAB? Simply put, we are here to empower innovation with outlandish thinking. We connect the dots of genius and help drive the digital health revolution.
NOSTALAB is a think tank with a contrarian focus. We offer the very best and brightest thinkers to analyze, establish and build markets. We like to make the competition cry foul.
First and foremost, John is a thinker. A thinker entrenched in the world of science, medicine and innovation. John is the founder of NOSTALAB--an amorphous, self-organizing neural network dedicated to the advancement of digital health.
Unwilling to accept the status quo, he’s a contrarian with a focus the future of health and wellness. A leading voice in the convergence of technology and health, Nosta helps define, dissect and deliberate global trends in digital health. He is also the #1 Kred-ranked social media influencer in health, and in the top 10 of both the Pharma100 and HIT100 lists, and a Google Glass Explorer. John also pens HEALTH CRITICAL for Forbes--a top global blog on health and technology with over 1.5 million page views in the last year. He has made appearances on Bloomberg Surveillance as a contributor and guest host.
John has a established reputation as a vocal advocate for strategic thinking and creativity. He has built his career on the “science of advertising,” a process where strategy and creativity work together for superior marketing. He has also been recognized for his ability to translate difficult medical and scientific concepts into material that can be more easily communicated to patients, clinicians and scientists. He is also a popular lecturer on a variety of topics--always presented in a unique and stimulating way.
John is actively redefining the role of social media and influence marketing in healthcare. He is also a major influencer in the digital space and ranked globally in the top .01% in marketing, health, doctors and social media.
Additionally, John has distinguished himself as a scientific thinker. Earlier in his career, John was a research associate at Harvard Medical School and has co-authored several papers with global thought-leaders in the field of cardiovascular physiology.
John cut his teeth at the "big" agencies including Ogilvy CommonHealth, where he has held a series of positions including Chief Creative Officer, Chief Strategic Officer and unit President.